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Filaggrin Fracture
Filaggrin is important for 
epidermal barrier function, 
and complete degradation 
of this protein yields natural 
moisturizing factors (NMF) 
that absorb water and 
maintain hydration of the 
skin. Hoste and colleagues 
demonstrated that caspase-14 
is critical for the generation 
of NMF and that filaggrin 
is a direct substrate of this 
enzyme. In mice deficient in 
caspase-14, filaggrin peptides 
accumulated, and levels of 
NMF, such as urocanic acid and 
pyrrolidone carboxylic acid, 
were decreased. Together, 
these results underscore a 
necessary role for caspase-14 
in filaggrin catabolism.  
See page 2233
Evolution of Epitope 
Recognition
Bullous pemphigoid (BP) 
results from autoantibody 
responses to several epitopes 
within the BP180 and BP230 
proteins. To test previous 
suggestions of epitope 
spreading, Di Zenzo and 
colleagues assessed the 
profiles of IgG autoantibody 
responses to these epitopes 
in a multicenter prospective 
study of 35 BP patients. 
Nearly 50% of these patients 
exhibited epitope spreading 
events, which occurred in 
the early stages of BP and 
were associated with disease 
severity. These findings 
ultimately support the notion 
that IgG recognition of the 
BP180 ectodomain occurs 
early in BP and is followed 
by recognition of additional 
epitopes. See page 2271
Cascade of Activation
Topical delivery of lympho-epithelial Kazal-
type-related inhibitor (LEKTI) bioactive 
fragments in order to treat the congenital 
erythro dermic ichthyosis, hair defects, and 
atopic manifestations that result from disregu-
lated barrier homeostasis in the life-threatening 
skin disease Netherton syndrome is the future of 
therapeutics for this disease. Towards this goal, 
Fortugno and colleagues identified physio-
logically active LEKTI fragments in human 
keratinocytes via antibody mapping, N-terminal sequencing, and site-specific mutagenesis 
studies. Individual fragments exhibited unique specificities and activities. In fact, some of 
the fragments specifically inhibited desquamation-related kallikreins (KLK5 and KLK14) 
and prevented KLK-mediated proteolysis of desmoglein-1, an important component of 
stratum corneum adhesion. See page 2223
Tricky Diagnosis
Dysfunction of the heme biosynthetic pathway under-
lies porphyria. Although diagnosis of porphyria types is 
typically obtained through biochemical analyses of urine, 
stool, erythrocytes, and plasma, accurate diagnosis may 
be difficult in the rare patients with dual porphyria. DNA 
analysis of the index patient with characteristics consistent 
with both hereditary coproporphyria (HCP) and variegate 
porphyria (VP) revealed novel mutations in both the cop-
roporphyrinogen oxidase (CPOX) and protoporphyrinogen 
oxidase (PPOX) genes, confirming a novel form of dual por-
phyria. The heterogeneous clinical phenotypes observed in 
this index patient and her relatives with dual porphyria underscore the lack of genotype–
phenotype correlations in common types of porphyria. See page 2249
Target the Pathway
Currently, treatment for the ichthyoses remains 
symptomatic and is commonly ineffective. 
Recent advances in our understanding of the 
bases of ichthyoses have opened up possibili-
ties for pathway-based therapies. Congenital 
Hemidysplasia with Ichthyosiform erythro-
derma and Limb Defects (CHILD) syndrome is 
a disorder of distal cholesterol metabolism and 
is notoriously unresponsive to treatment. Paller 
and colleagues found that skin lesions in two 
patients responded to topical application of 
cholesterol, the deficient pathway end-product, 
in combination with statins, which prevent the 
accumulation of toxic metabolites. This mechanism-based therapeutic approach offers a 
promising avenue for topical therapy for other disorders of the distal cholesterol metab-
olism pathway. See page 2242
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